CKW Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

CKW Financial Group’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-700	Closed	-$46K	–	195
2024 Q4	$46K	Hold	700	–	–	0.01%	137
2024 Q3	$49K	Hold	700	–	–	0.01%	138
2024 Q2	$57K	Hold	700	–	–	0.01%	127
2024 Q1	$61K	Hold	700	–	–	0.01%	126
2023 Q4	$67K	Hold	700	–	–	0.01%	121
2023 Q3	$62K	Hold	700	–	–	0.01%	116
2023 Q2	$61K	Hold	700	–	–	0.01%	117
2023 Q1	$68K	Hold	700	–	–	0.01%	101
2022 Q4	$72K	Sell	700 -100	-13%	-$9.39K	0.01%	87
2022 Q3	$68K	Hold	800	–	–	0.01%	93
2022 Q2	$68K	Hold	800	–	–	0.01%	96
2022 Q1	$63K	Buy	800 +150	+23%	+$12.6K	0.01%	115
2021 Q4	$60K	Hold	650	–	–	0.01%	112
2021 Q3	$50K	Hold	650	–	–	0.01%	120
2021 Q2	$55K	Buy	650 +200	+44%	+$15.9K	0.01%	115
2021 Q1	$34K	Hold	450	–	–	0.01%	124
2020 Q4	$39K	Buy	450 +200	+80%	+$15.9K	0.01%	113
2020 Q3	$19K	Hold	250	–	–	﹤0.01%	126
2020 Q2	$31K	Hold	250	–	–	0.01%	108
2020 Q1	$21K	Buy	+250	New	+$21.5K	0.01%	114
2015 Q3	–	Sell	-140	Closed	-$19K	–	177
2015 Q2	$19K	Hold	140	–	–	0.01%	219
2015 Q1	$17K	Hold	140	–	–	0.01%	237
2014 Q4	$13K	Buy	+140	New	+$11.6K	0.01%	261

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CKW Financial Group's BMRN Position: Q1 2025 in Review

CKW Financial Group sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2025, closing a stake of 700 shares — an estimated $46K sold.

CKW Financial Group first reported a position in BMRN in Q4 2014 and held it in 23 quarters. The position peaked at $72K in Q4 2022. 584 funds tracked by Wall St. Rank hold BMRN as of Q1 2025.

CKW Financial Group reported no remaining BioMarin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
CKW Financial Group sold 700 BioMarin Pharmaceuticals shares in Q1 2025, an estimated $46K.
CKW Financial Group first reported a position in BioMarin Pharmaceuticals in Q4 2014 and held it in 23 quarters.
CKW Financial Group's BioMarin Pharmaceuticals position peaked at $72K in Q4 2022.
584 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2025.

Based on CKW Financial Group's 13F filing for Q1 2025, filed 16 May 2025.